UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 378

Sortiert nach

In Vitro and in Vivo Melanogenesis Inhibition by Biochanin A from Trifolium pratense

Bioscience, biotechnology, and biochemistry, 2011, Vol.75 (5), p.914-918

2011

Volltextzugriff (PDF)

Integrated analysis identifies GABRB3 as a biomarker in prostate cancer

BMC medical genomics, 2024-01, Vol.17 (1), p.41-41, Article 41

2024

Volltextzugriff (PDF)

Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer

Scientific reports, 2015-09, Vol.5 (1), p.14045, Article 14045

2015

Volltextzugriff (PDF)

Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy

International journal of molecular sciences, 2016-12, Vol.17 (12), p.1970-1970

2016

Volltextzugriff (PDF)

Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer

Scientific reports, 2015-02, Vol.5 (1), p.8556-8556, Article 8556

2015

Volltextzugriff (PDF)

Genetic association analysis identifies a role for ANO5 in prostate cancer progression

Cancer medicine (Malden, MA), 2020-04, Vol.9 (7), p.2372-2378

2020

Volltextzugriff (PDF)

Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer

International journal of molecular sciences, 2016-12, Vol.17 (12), p.1996-1996

2016

Volltextzugriff (PDF)

5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level

Journal of the Formosan Medical Association, 2015-09, Vol.114 (9), p.865-871

2015

Volltextzugriff (PDF)

Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy

Cancer medicine (Malden, MA), 2019-06, Vol.8 (6), p.2777-2783

2019

Volltextzugriff (PDF)

The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells

Anticancer research, 2023-04, Vol.43 (4), p.1521

2023

Volltextzugriff (PDF)

Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products/TGF‐β pathway

Environmental toxicology, 2021-06, Vol.36 (6), p.1080-1089

2021

Volltextzugriff (PDF)

Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: Technical considerations and surgical outcomes

Asian journal of surgery, 2015-01, Vol.38 (1), p.6-12

2015

Volltextzugriff (PDF)

Prognostic Value of CD1B in Localised Prostate Cancer

International journal of environmental research and public health, 2019-11, Vol.16 (23), p.4723

2019

Volltextzugriff (PDF)

External validation of Solomon–Greenwell nomogram for female bladder outlet obstruction

Neurourology and urodynamics, 2022-02, Vol.41 (2), p.626-632

2022

Volltextzugriff (PDF)

ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysis

The Prostate, 2023-05, Vol.83 (6), p.602-611

2023

Volltextzugriff (PDF)

Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf-DAPK Complex by Raf Inhibitor Combination Therapy

Cancer research (Chicago, Ill.), 2015-09, Vol.75 (17), p.3568-3582

2015

Volltextzugriff (PDF)

A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer

Journal of cellular and molecular medicine, 2018-07, Vol.22 (7), p.3661-3670

2018

Volltextzugriff (PDF)

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer

International journal of cancer, 2014-12, Vol.135 (11), p.2661-2667

2014

Volltextzugriff (PDF)

Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival

Scientific reports, 2016-02, Vol.6 (1), p.22124-22124, Article 22124

2016

Volltextzugriff (PDF)

Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients

European journal of cancer (1990), 2013-11, Vol.49 (17), p.3729-3737

2013

Volltextzugriff (PDF)

Prognostic Significance of Cyclin D1 Polymorphisms on Prostate-Specific Antigen Recurrence After Radical Prostatectomy

Annals of surgical oncology, 2013-12, Vol.20 (Suppl 3), p.492-499

2013

Volltextzugriff (PDF)

Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients

Archives of toxicology, 2014-04, Vol.88 (4), p.901-911

2014

Volltextzugriff (PDF)

LAPAROSCOPIC COMPLETE URINARY TRACT EXENTERATION WITH THE SPECIMEN WITHDRAWN TRANSVAGINALLY

BJU international, 2009-06, Vol.103 (11), p.1584-1584

2009

Volltextzugriff (PDF)

An Atrophic Crossed Fused Kidney With an Ectopic Vaginal Ureter Causing Urine Incontinence

Urology (Ridgewood, N.J.), 2010-07, Vol.76 (1), p.55-56

2010

Volltextzugriff (PDF)

Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease

Clinica chimica acta, 2010-09, Vol.411 (17), p.1232-1237

2010

Volltextzugriff (PDF)

1 – 25 von 378

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(373)
Mit Volltextzugriff
(329)

Publikationsform

Artikel
(378)

Sprache

Englisch
(378)
Japanisch
(94)

Erscheinungsjahr

n.n

Thema

Science & Technology
(354)
Humans
(315)
Life Sciences & Biomedicine
(310)
Male
(188)
Female
(178)
Middle Aged
(113)
Animals
(99)
Adult
(82)
Aged
(81)
Biological And Medical Sciences
(79)
Medical Sciences
(62)
Risk Factors
(58)
Mice
(49)
Oncology
(47)
Prognosis
(39)
Prospective Studies
(39)
Cardiovascular System & Cardiology
(37)
Polymorphism, Single Nucleotide
(32)
Science & Technology - Other Topics
(32)
Cardiac & Cardiovascular Systems
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro and in Vivo Melanogenesis Inhibition by Biochanin A from Trifolium pratense

Integrated analysis identifies GABRB3 as a biomarker in prostate cancer

Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer

Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer

Genetic association analysis identifies a role for ANO5 in prostate cancer progression

Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer

5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level

Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy

The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells

Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products/TGF‐β pathway

Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: Technical considerations and surgical outcomes

Prognostic Value of CD1B in Localised Prostate Cancer

External validation of Solomon–Greenwell nomogram for female bladder outlet obstruction

ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysis

Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf-DAPK Complex by Raf Inhibitor Combination Therapy

A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer

Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival

Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients

Prognostic Significance of Cyclin D1 Polymorphisms on Prostate-Specific Antigen Recurrence After Radical Prostatectomy

Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients

LAPAROSCOPIC COMPLETE URINARY TRACT EXENTERATION WITH THE SPECIMEN WITHDRAWN TRANSVAGINALLY

An Atrophic Crossed Fused Kidney With an Ectopic Vaginal Ureter Causing Urine Incontinence

Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease

Aktive Filter

Suchergebnisse filtern